Instapill is a finished-dose manufacturer based in India. It appears in 11 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by US FDA, MHRA (UK) and EMA. Its most recent recorded inspection, by US FDA, closed on 13 September 2024 as VAI. Customs aggregates show $518K of exports covering 64 molecules to 3 destinations in 2026 so far.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| BENGALURU SOUTH DISTRICT, India | Not on file |
| Bengaluru, India | 3014463103 |
| Bengaluru Rural, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | 11 | 1 |
| US FDA | None | 1 |
| MHRA (UK) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $518K | 3 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Instapill comes back tiered against every other supplier able to file there.
Start for free